Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Azd3229
1. Azd3229
2. 2248003-60-1
3. Azd-3229
4. 9zgc48p3rv
5. Nb003 Free Base
6. Nb-003 Free Base
7. N-[4-[[5-fluoro-7-(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]-2-(4-propan-2-yltriazol-1-yl)acetamide
8. N-(4-((5-fluoro-7-(2-methoxyethoxy)quinazolin-4-yl)amino)phenyl)-2-(4-propan-2-yltriazol-1-yl)acetamide
9. Refchem:116038
10. N-[4-[[5-fluoro-7-(2-methoxyethoxy)-4-quinazolinyl]amino]phenyl]-4-(1-methylethyl)-1h-1,2,3-triazole-1-acetamide
11. Chembl4216473
12. 2248003-60-1 (free Base)
13. N-{4-[(6,7-dimethoxyquinazolin-4-yl)oxy]phenyl}-2-[4-(propan-2-yl)-1h-1,2,3-triazol-1-yl]acetamide
14. 1h-1,2,3-triazole-1-acetamide, N-(4-((5-fluoro-7-(2-methoxyethoxy)-4-quinazolinyl)amino)phenyl)-4-(1-methylethyl)-
15. N-(4-((5-fluoro-7-(2-methoxyethoxy)quinazolin-4-yl)amino)phenyl)-2-(4-(propan-2-yl)-1h-(1,2,3)triazol-1-yl)acetamide
16. N-(4-((5-fluoro-7-(2-methoxyethoxy)quinazolin-4-yl)amino)phenyl)-2-(4-isopropyl-1h-1,2,3-triazol-1-yl)acetamide
17. Ubavitinib [inn]
18. Unii-9zgc48p3rv
19. Orb1301814
20. Schembl20546500
21. Schembl29394680
22. Schembl29883904
23. C24h26fn7o3
24. Gtpl12703
25. Tqp0910
26. Glxc-20855
27. Azd 3229
28. Azd3229?
29. Ex-a2637
30. Ypd00360
31. Bdbm50459416
32. Nsc813380
33. S8780
34. Akos037515681
35. Nsc-813380
36. Da-71196
37. Ms-28916
38. Hy-112802
39. Cs-0065717
40. G16506
41. F8h
42. N-[4-[[5-fluoro-7-(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]-2-(4-isopropyltriazol-1-yl)acetamide
| Molecular Weight | 479.5 g/mol |
|---|---|
| Molecular Formula | C24H26FN7O3 |
| XLogP3 | 3.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 10 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 116 |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 667 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
59
PharmaCompass offers a list of Ubavitinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ubavitinib manufacturer or Ubavitinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ubavitinib manufacturer or Ubavitinib supplier.
A Ubavitinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ubavitinib, including repackagers and relabelers. The FDA regulates Ubavitinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ubavitinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ubavitinib supplier is an individual or a company that provides Ubavitinib active pharmaceutical ingredient (API) or Ubavitinib finished formulations upon request. The Ubavitinib suppliers may include Ubavitinib API manufacturers, exporters, distributors and traders.
Ubavitinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ubavitinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ubavitinib GMP manufacturer or Ubavitinib GMP API supplier for your needs.
A Ubavitinib CoA (Certificate of Analysis) is a formal document that attests to Ubavitinib's compliance with Ubavitinib specifications and serves as a tool for batch-level quality control.
Ubavitinib CoA mostly includes findings from lab analyses of a specific batch. For each Ubavitinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ubavitinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Ubavitinib EP), Ubavitinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ubavitinib USP).
